NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1508938192 M.D.
Verify on CMS → Joseph Gall, M.D.
Hematology & Oncology Physician in Greensburg, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 62 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Joseph Gall, M.D. filed 1,313 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Greensburg, Pennsylvania, prescribing 89% generic.
- 1K
- Part D claims, 2024
- 89%
- generic prescribing
- ≥79th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Joseph Gall, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1508938192), first enumerated 11/15/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,313 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Joseph Gall, M.D.'s individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1508938192 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1508938192
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- RX-MID 1,313
- BOOK-LIGHT 657 in Pennsylvania
- PHOTO-ENUM Kanu Patel, MD · 2006
Joseph Gall, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,313 ≥ 79th percentile 79% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Joseph Gall, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Joseph Gall, M.D.?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,313 48% vs specialty avg
Specialty distribution in Pennsylvania
How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1508938192 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/15/2006 |
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Joseph Gall, M.D.. To verify Joseph Gall, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Joseph Gall, M.D. - brand share 11.0%
Hematology & Oncology Physician average
11% brand-name claims vs 89% generic, on 1,313 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,313
Total Claims
$71K
Total Drug Cost
62
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,367.167
- Total Day Supply
- 29,516
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $51K
- Generic Drug Cost
- $19K
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 87.3 years
- Avg HCC Risk Score
- 1.92
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 0, 65-74: N/A, 75-84: N/A, 85+: 39
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Joseph Gall, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
98 claims
- Furosemide
Furosemide
98 claims
- Eliquis
Eliquis
74 claims
- Isosorbide Mononit…
Isosorbide Mononitrate Er
56 claims
- Clopidogrel
Clopidogrel
54 claims
- Metoprolol Tartrate
Metoprolol Tartrate
51 claims
- Amlodipine Besylate
Amlodipine Besylate
46 claims
- Losartan Potassium
Losartan Potassium
45 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 98 |
| Furosemide | 98 |
| Eliquis Apixaban | 74 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 56 |
| Clopidogrel Clopidogrel Bisulfate | 54 |
| Metoprolol Tartrate | 51 |
| Amlodipine Besylate | 46 |
| Losartan Potassium | 45 |
| Famotidine | 44 |
| Sertraline Hcl | 42 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Joseph Gall, M.D. fits within the Hematology & Oncology Physician landscape nationally.
11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider
Joseph Gall, M.D.'s 1,313 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gall, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Gall.
One of 657 Hematology & Oncology Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Abdullateef Abdulkareem
M.D.
Lancaster, PA
Dr. Charles Abrams
MD
Philadelphia, PA
Tala Achkar
Pittsburgh, PA
Dr. Monica Adedeji
MD, MPH
Hershey, PA
Dr. Giridhar Adiga
MD
Ephrata, PA
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Joseph Gall, M.D.'s specialty? ▼
Joseph Gall, M.D. specializes in Hematology & Oncology Physician and practices in Greensburg, Pennsylvania. Credentials: M.D..
How much does Joseph Gall, M.D. prescribe under Medicare Part D? ▼
In 2024, Joseph Gall, M.D. wrote 1,313 Medicare Part D claims totaling $71K in drug costs for 62 beneficiaries.
Where is Joseph Gall, M.D. located? ▼
Joseph Gall, M.D. is located at 562 SHEARER ST, Greensburg, PA, 15601. Phone: (724) 832-3960.
What is Joseph Gall, M.D.'s NPI number? ▼
Joseph Gall, M.D.'s National Provider Identifier (NPI) is 1508938192, issued on 11/15/2006.
Does Joseph Gall, M.D. prescribe more brand-name or generic drugs? ▼
Joseph Gall, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $51K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Joseph Gall, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Joseph Gall, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Furosemide, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Joseph Gall, M.D. accept Medicare? ▼
Joseph Gall, M.D. appears in CMS Medicare data with 1,313 Part D claims and 62 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Joseph Gall, M.D.'s credentials? ▼
Joseph Gall, M.D.'s NPI is 1508938192 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.